Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T87325 | Target Info | |||
Target Name | COVID-19 papain-like proteinase (PL-PRO) | ||||
Synonyms |
COVID-19 papain-like proteinase; COVID-19 PL2-PRO; COVID-19 PL-PRO; COVID-19 main proteinase; COVID-19 non-structural protein 3
Click to Show/Hide
|
||||
Gene Name | COVID-19 rep; COVID-19 1a-1b | ||||
Biochemical Class | Coronaviruses polyprotein 1ab family | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | Insulin-degrading enzyme (IDE) | Successful Target | ||||
UniProt ID | IDE_HUMAN | |||||
Gene Name | IDE | |||||
Synonyms |
Insulysin; Insulinase; Insulin protease; Abeta-degrading protease
Click to Show/Hide
|
|||||
Representative Drug(s) | SPI-1005 | Drug Info | IC50 = 14 nM | [1] | ||
Co-Target Name | Indoleamine 2,3-dioxygenase 1 (IDO1) | Successful Target | ||||
UniProt ID | I23O1_HUMAN | |||||
Gene Name | IDO1 | |||||
Synonyms |
Indoleamine-pyrrole 2,3-dioxygenase; INDO; IDO-1; IDO
Click to Show/Hide
|
|||||
Representative Drug(s) | SPI-1005 | Drug Info | Ki = 94 nM | [2] | ||
Co-Target Name | Soluble epoxide hydrolase (EPHX2) | Clinical trial Target | ||||
UniProt ID | HYES_HUMAN | |||||
Gene Name | EPHX2 | |||||
Synonyms |
Bifunctional epoxide hydrolase 2
Click to Show/Hide
|
|||||
Representative Drug(s) | SPI-1005 | Drug Info | IC50 = 110 nM | [3] | ||
Co-Target Name | Lysyl oxidase homolog 2 (LOXL2) | Clinical trial Target | ||||
UniProt ID | LOXL2_HUMAN | |||||
Gene Name | LOXL2 | |||||
Synonyms |
Lysyl oxidaserelated protein WS914; Lysyl oxidaserelated protein 2; Lysyl oxidaselike protein 2; LOXL2
Click to Show/Hide
|
|||||
Representative Drug(s) | Disulfiram | Drug Info | IC50 = 150 nM | [4] | ||
Co-Target Name | Monoglyceride lipase (MAGL) | Clinical trial Target | ||||
UniProt ID | MGLL_HUMAN | |||||
Gene Name | MGLL | |||||
Synonyms |
Monoacylglycerol lipase; MGL; Lysophospholipaselike; Lysophospholipase-like; Lysophospholipase homolog; HUK5; HU-K5
Click to Show/Hide
|
|||||
Representative Drug(s) | Disulfiram | Drug Info | IC50 = 360 nM | [5] | ||
Co-Target Name | Macrophage migration inhibitory factor (MIF) | Clinical trial Target | ||||
UniProt ID | MIF_HUMAN | |||||
Gene Name | MIF | |||||
Synonyms |
Phenylpyruvate tautomerase; MMIF; L-dopachrome tautomerase; L-dopachrome isomerase; Glycosylation-inhibiting factor; GLIF; GIF
Click to Show/Hide
|
|||||
Representative Drug(s) | SPI-1005 | Drug Info | Ki = 570 nM | [6] | ||
Co-Target Name | UDP-glucose 4-epimerase (GALE) | Literature-reported Target | ||||
UniProt ID | GALE_HUMAN | |||||
Gene Name | GALE | |||||
Synonyms |
UDP-galactose4-epimerase; UDP-galactose4'-epimerase; UDP-galactose 4-epimerase; UDP-N-acetylglucosamine 4-epimerase; UDP-N-acetylgalactosamine 4-epimerase; UDP-GlcNAc 4-epimerase; UDP-GalNAc 4-epimerase; Galactowaldenase
Click to Show/Hide
|
|||||
Representative Drug(s) | SPI-1005 | Drug Info | IC50 = 14 nM | [7] | ||
Co-Target Name | Lysyl oxidase (LOX) | Literature-reported Target | ||||
UniProt ID | LYOX_HUMAN | |||||
Gene Name | LOX | |||||
Synonyms |
Protein-lysine 6-oxidase
Click to Show/Hide
|
|||||
Representative Drug(s) | Disulfiram | Drug Info | IC50 = 320 nM | [4] | ||
Co-Target Name | Histone-lysine N-methyltransferase EHMT2 (EHMT2) | Literature-reported Target | ||||
UniProt ID | EHMT2_HUMAN | |||||
Gene Name | EHMT2 | |||||
Synonyms |
Protein G9a; NG36; Lysine N-methyltransferase 1C; KMT1C; Histone H3-K9 methyltransferase 3; HLA-B-associated transcript 8; H3-K9-HMTase 3; G9A; Euchromatic histone-lysine N-methyltransferase 2; C6orf30; BAT8
Click to Show/Hide
|
|||||
Representative Drug(s) | SPI-1005 | Drug Info | IC50 = 400 nM | Click to Show More | [8] | |
2 | Disulfiram | Drug Info | IC50 = 600 nM | [8] | ||
Co-Target Name | Euchromatic histone-lysine N-methyltransferase 1 (EHMT1) | Literature-reported Target | ||||
UniProt ID | EHMT1_HUMAN | |||||
Gene Name | EHMT1 | |||||
Synonyms |
EHMT1
Click to Show/Hide
|
|||||
Representative Drug(s) | SPI-1005 | Drug Info | IC50 = 730 nM | [8] | ||
Co-Target Name | Lysyl oxidase homolog 4 (LOXL4) | Co-Target | ||||
UniProt ID | LOXL4_HUMAN | |||||
Gene Name | LOXL4 | |||||
Synonyms |
Lysyl oxidase-like protein 4; Lysyl oxidase-related protein C
Click to Show/Hide
|
|||||
Representative Drug(s) | Disulfiram | Drug Info | IC50 = 59 nM | [4] | ||
Co-Target Name | Lysyl oxidase homolog 3 (LOXL3) | Co-Target | ||||
UniProt ID | LOXL3_HUMAN | |||||
Gene Name | LOXL3 | |||||
Synonyms |
Lysyl oxidase-like protein 3
Click to Show/Hide
|
|||||
Representative Drug(s) | Disulfiram | Drug Info | IC50 = 93 nM | [4] | ||
Co-Target Name | Gasdermin-D (GSDMD) | Co-Target | ||||
UniProt ID | GSDMD_HUMAN | |||||
Gene Name | GSDMD | |||||
Synonyms |
Gasdermin domain-containing protein 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Disulfiram | Drug Info | IC50 = 400 nM | [9] | ||
Co-Target Name | Gamma-butyrobetaine dioxygenase (BBOX1) | Co-Target | ||||
UniProt ID | BODG_HUMAN | |||||
Gene Name | BBOX1 | |||||
Synonyms |
Gamma-butyrobetaine hydroxylase; Gamma-BBH; Gamma-butyrobetaine,2-oxoglutarate dioxygenase
Click to Show/Hide
|
|||||
Representative Drug(s) | SPI-1005 | Drug Info | IC50 = 690 nM | [10] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening. Eur J Med Chem. 2019 Oct 1;179:557-566. | ||||
REF 2 | Recent advances in the discovery of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors. Med. Chem. Commun. 2019;10:1740-1754. | ||||
REF 3 | Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain. J Med Chem. 2019 Sep 26;62(18):8443-8460. | ||||
REF 4 | Inhibition of the LOX enzyme family members with old and new ligands. Selectivity analysis revisited. Bioorg Med Chem Lett. 2018 Oct 1;28(18):3113-3118. | ||||
REF 5 | Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors. J Med Chem. 2017 Jan 12;60(1):4-46. | ||||
REF 6 | Advances and Insights for Small Molecule Inhibition of Macrophage Migration Inhibitory Factor. J Med Chem. 2018 Sep 27;61(18):8104-8119. | ||||
REF 7 | Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness. Bioorg Med Chem Lett. 2006 Nov 15;16(22):5744-7. | ||||
REF 8 | Inhibition of histone lysine methyltransferases G9a and GLP by ejection of structural Zn(II). Bioorg Med Chem Lett. 2018 Apr 15;28(7):1234-1238. | ||||
REF 9 | Gasdermin D (GSDMD) as a new target for the treatment of infection. Med. Chem. Commun. 2019;10:660-667. | ||||
REF 10 | Ejection of structural zinc leads to inhibition of gamma-butyrobetaine hydroxylase. Bioorg Med Chem Lett. 2014 Nov 1;24(21):4954-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.